Tuesday, May 26, 2020

Regeneron Announces Pricing of Secondary Offering of its Common Stock Held by Sanofi

TARRYTOWN, N.Y., May 26, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the pricing of the underwritten public secondary offering of 11,831,496 shares of its common stock held by Sanofi at a price of $515.00 per share. Regeneron also agreed to purchase...



from PR Newswire: https://ift.tt/2ZFpcm3

No comments:

Post a Comment